Treehouse Eyes
Treehouse Eyes is a Boulder, CO-based pediatric eye care company that operates a national network of 40+ optometric partner practices delivering myopia management treatments to children, combining tiered subscription-based practice enablement with direct consumer acquisition via virtual consultations and a doctor locator.
- Company typePrivate
- Founded2016
- HeadquartersBoulder, United States
- Headcount11–50
- GTM typeB2C
- OfferingServices
What Treehouse Eyes does
Treehouse Eyes is a Boulder, Colorado-based pediatric specialty eye care company founded in 2015-2016 by Dr. Gary Gerber, OD, and Matt Oerding, focused on the treatment and management of myopia (nearsightedness) in children. The company operates a hybrid B2B2C model: it sells tiered subscription programs (Clinical at $249/month, Enable at $399/month, Ascend at $999/month, Premier at custom multi-year pricing with geographic exclusivity) to independent optometric practices, equipping them with clinical protocols, marketing tools, and training to deliver myopia management services. The company itself also staffs and supports flagship "Centers of Excellence" and drives direct patient demand through free virtual consultations, a risk-assessment quiz, content marketing, and a doctor locator spanning 20+ US states.
The clinical offering centers on four treatment modalities that address axial eye elongation rather than merely correcting refractive error: custom KIDS Lenses (overnight orthokeratology using 3D corneal mapping), MiSight 1-day soft contact lenses with CooperVision's ActivControl technology, low-dose prescription atropine eye drops, and Essilor Stellest myopia control spectacle lenses. Treatment decisions are guided by the proprietary Treehouse Vision System, a clinical protocol derived from the landmark CAMP study of 342 children, and supported by axial length biometry for tracking eye growth. In 2025, the company launched a ChatGPT-based AI version of the Vision System that allows clinicians to input patient details by voice or text and receive treatment recommendations.
The company's go-to-market combines consumer education (content marketing, virtual consultations, risk quizzes) with practice enablement (Academy training, MY-TDA patient education tool, AMP automated marketing program). Revenue is generated from partner practice subscriptions and downstream patient treatment services billed by partner practices. The network encompasses 40+ independent optometric practices across 20+ US states and has cumulatively treated over 20,000 myopic children. The company has raised approximately $8.2 million in disclosed funding, including a $7,999,977 round in April 2023, and remains privately held under founder control.
Treehouse Eyes firmographics
Firmographics- Name
- Treehouse Eyes
- Legal name
- Treehouse Eyes
- Website
- https://treehouseeyes.com
- Company type
- Private
- Founded year
- 2016
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Treehouse Eyes is a Boulder, CO-based pediatric eye care company that operates a national network of 40+ optometric partner practices delivering myopia management treatments to children, combining tiered subscription-based practice enablement with direct consumer acquisition via virtual consultations and a doctor locator.
- Ownership category
- akta.pro rank
Treehouse Eyes industry classification
Industry- Product category
- Pediatric Myopia Management
- NAICS
- Offices of Optometrists (62132), Offices of Optometrists (621320)
- SIC
- Ophthalmic Goods (3851)
- akta.pro primary industry
- Contact Lens Specialty & Myopia Control (HLAKAKAK)
- akta.pro secondary industries
- Optometry Clinics (Primary Eye Care) (HLAKAKAB), Contact Lenses & Care Systems (Soft/RGP/Scleral Lenses; Cleaning/Disinfection Solutions) (HLAHAJAE), Pediatric Ophthalmology & Orthoptics Devices (Amblyopia Therapy, Strabismus Measurement & Treatment) (HLAHAJAM)
Keywords
Where Treehouse Eyes is headquartered
LocationHeadquarters
- HQ city
- Boulder
- HQ country
- United States
- HQ region
- North America
Markets served
Treehouse Eyes business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure
Revenue model
- Partner Practice Subscriptions: Treehouse Eyes generates recurring subscription revenue from optometric practices through tiered membership programs (Clinical at $249/month, Enable at $399/month, Ascend at $999/month, and Premier with custom pricing). These programs provide clinical protocols, training, marketing tools, patient education software, and practice development support.
- Myopia Treatment Services: Revenue from direct patient treatment services through partner eye doctors including overnight lenses (Ortho-K/KIDS lenses), daytime soft contact lenses (MiSight), prescription atropine eye drops, and myopia control glasses (Stellest). Each partner practice sets their own pricing for treatments, which may vary by treatment type.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Monthly | Clinical Program - Foundational support for practices beginning myopia management |
| Subscription | Monthly | Enable Program - Structured implementation for practices ready to run consistent myopia programs |
| Subscription | Monthly | Ascend Program - Comprehensive myopia program development for committed practices |
| Subscription | Multi-year contract | Premier Program - Full-service offering with geographic exclusivity |
Go-to-market motion1 record
Distribution channels2 records
Marketing channels9 records
Treehouse Eyes product offering
Product offeringCore offering
Treehouse Eyes provides pediatric myopia management services for children with nearsightedness, offering FDA-approved soft contact lenses (MiSight 1-day), custom overnight orthokeratology lenses (KIDS Lenses), prescription atropine eye drops, and Stellest myopia control glasses. Treatment is delivered through a network of partner optometric practices supported by the proprietary Treehouse Vision System clinical protocol and AI-assisted treatment planning.
Product overview
Treehouse Eyes offers a specialized pediatric myopia management platform with four core treatment products: MiSight® 1 day soft contact lenses (FDA-approved for ages 8-12), KIDS Ortho-K overnight lenses (custom overnight corneal reshaping), prescription atropine eye drops (customized low-dose formulation), and Stellest® myopia control glasses (FDA-approved spectacle lenses). These treatments work by managing axial eye elongation rather than merely correcting blurry vision. The company also provides a suite of practice development programs—Clinical, Enable, Ascend, and Premier tiers—offering the Treehouse Vision System® clinical protocol with AI-powered treatment recommendations (launched 2025), MY-TDA patient education and tracking tool, AMP automated marketing, and Academy training. The product portfolio ranges from direct patient treatments to B2B practice management solutions, all focused on slowing or stopping myopia progression in children.
Differentiator
Problem solved
Functional benefit
Brands
- Treehouse Eyes Clinical: Foundational support program for practices beginning their myopia management journey at $249/month, including clinical protocols, patient education tools, and monthly newsletters.
- Treehouse Eyes Enable
- Treehouse Eyes Ascend
- Treehouse Eyes Premier
- KIDS Lenses
- Treehouse Vision System
- Treehouse Eyes Academy
- MY-TDA
- Treehouse Eyes AMP
Products and services
- MiSight 1-day Soft Contact Lenses FDA-approved daily disposable soft contact lenses with ActivControl Technology designed to slow the progression of myopia in children. Prescribed and dispensed by Treehouse Eyes partner optometrists as part of a structured myopia management program.
- KIDS Lenses (Overnight Orthokeratology Lenses) Custom-fitted orthokeratology (Ortho-K) lenses worn overnight to temporarily reshape the cornea and provide clear daytime vision without glasses or contacts, while simultaneously slowing myopia progression in children. Exclusive to the Treehouse Eyes partner network.
- Prescription Atropine Eye Drops Compounded low-dose atropine eye drops prescribed by Treehouse Eyes clinicians as a pharmacological option to slow myopia progression in children, frequently combined with optical treatments in a customized plan.
- Essilor Stellest Myopia Control Glasses Essilor Stellest spectacle lenses featuring Highly Aspherical Lenslet Technology, prescribed by Treehouse Eyes clinicians as a non-contact-lens option to slow myopia progression in children.
- Treehouse Vision System Proprietary clinical protocol and AI-assisted platform that combines axial length biometry, 3D corneal mapping, and standardized treatment workflows to help Treehouse Eyes clinicians build personalized myopia management plans for each child.
- MY-TDA (Treatment Decision Algorithm) Proprietary Treatment Decision Algorithm embedded in the Treehouse Vision System that synthesizes patient data (axial length, corneal topography, prescription history) to recommend and adjust myopia treatments for pediatric patients.
Quantifiable outcome
- 30-60% slowed myopia progression compared to standard single-vision glasses
- +2 more outcomes
Companies that use Treehouse Eyes
Customer profileNamed customers7 records
Segments3 records
Ideal customer profiles2 records
Treehouse Eyes technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability1 record
Feature5 records
Treehouse Eyes partnerships and signals
Strategic signalPartnerships
Seven partnerships are on record, tiered preferred and core.
- CooperVisionpreferredCooperVision is the preferred vendor for Treehouse Eyes partner practices. The company offers discounts and programs available through this partnership. Treehouse Eyes receives sneak previews of new products and tools to share with partner practices. MiSight 1-day contact lenses are a key product in the partnership.
- EssilorcoreEssilor Stellest lenses are offered through Treehouse Eyes practices. These FDA-approved myopia control spectacle lenses use lenslet technology and represent a key treatment option in the Treehouse Eyes protocol.
- Pacific Rims Optometry GroupcoreSan Francisco-based practice led by Dr. Selena Chan that partnered with Treehouse Eyes to implement myopia management protocols. The practice now treats myopia differently and has grown patient volume significantly through the partnership.
- Insight Vision Center OptometrycoreCosta Mesa, CA practice led by Dr. Thanh Mai that partnered with Treehouse Eyes to leverage execution and marketing expertise. The practice has changed how it approaches treating myopia and is building patient volume faster than before.
- Vision Quest EyecarecoreIndiana practice (Greenwood and Geist/McCordsville locations) led by Dr. Christopher Browning that signed up with Treehouse Eyes in 2019. The practice now signs up 10-12 children per month in myopia management treatment plans compared to 5-6 per year before partnering.
- LOOK OptometrycoreManhattan Beach, CA practice led by Dr. Ryan Stybel that partnered with Treehouse Eyes to shape the practice to specialize and excel in Myopia Management while improving all aspects of patient care, community involvement, and practice growth.
- Independent Optometric Practices (40+ locations)coreOver 40 independent optometric practices across 20+ US states are part of the Treehouse Eyes network. These practices have advanced training in pediatric myopia management and use modern biometry technology to accurately track eye growth.
Scale indicators5 records
Recent moves6 records
Expansion highlights5 records
Treehouse Eyes competitors and assessment
Company assessmentBroad incumbents
- CooperVision (MiSight): CooperVision manufactures MiSight 1-day, the FDA-approved contact lens that is a core Treehouse Eyes treatment. As both a key supplier and broader contact-lens incumbent, CooperVision overlaps on myopia management through its own direct-to-consumer MiSight programs and practitioner partnerships.
- EssilorLuxottica (Stellest): Essilor manufactures the Stellest myopia control spectacle lens, a flagship Treehouse Eyes product. The global optical-goods giant also distributes competing lenses, frames, and practice-enablement services, making it both a partner and a broad incumbent in the same clinical category.
- Pearle Vision: National optical retail chain (EssilorLuxottica-owned) increasingly offering pediatric myopia management services alongside routine eye exams. Competes for the same parent customer through standardized retail access and broader insurance-network participation than independent Treehouse Eyes practices.
- LensCrafters: National optical retailer (EssilorLuxottica) with a growing pediatric myopia management offering. Brings scale, brand recognition, and insurance participation that directly compete with independent Treehouse Eyes practices for parent customers seeking myopia care.
Direct peers
- Brien Holden Vision Institute: Non-profit research and commercialization institute that has been foundational in myopia management science, including MiSight clinical development and practitioner education globally. Overlaps with Treehouse Eyes on myopia-control clinical protocols and practitioner enablement.
- Ortho-K Networks (orthokeratology practices): Independent orthokeratology-focused practices and networks offering overnight contact lens myopia control for children. Compete directly with Treehouse Eyes on the Ortho-K treatment modality and pediatric patient acquisition, though typically without Treehouse Eyes' integrated multi-modality protocol.
Emerging players
- MyopiaCare (by Vision Source): Vision Source is a large optometric alliance that has invested in myopia management programs for its member practices. Competes with Treehouse Eyes by giving independent optometrists an alternative network-backed myopia protocol with similar training, marketing, and clinical-support services.
- Pediatric Eye Center (MyKidsEyes): Independent pediatric optometry practices and small networks offering myopia management for children. Compete with Treehouse Eyes for the same pediatric patient demographic, though typically without Treehouse Eyes' standardized subscription-based practice enablement model.
Others
- Atropine 0.01% Compounding Pharmacies (e.g., ImprimisRx): Compounding pharmacies that supply low-dose atropine eye drops for myopia management, one of Treehouse Eyes' core treatment modalities. They are upstream suppliers rather than direct competitors, but their pricing and formulation choices shape Treehouse Eyes' delivery economics.
- Vision Council of America (myopia education initiatives): Industry trade association that funds consumer awareness campaigns around myopia management and pediatric eye health. Adjacent ecosystem participant that drives category awareness benefiting Treehouse Eyes, while also enabling competing optometric networks and retailers.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Treehouse Eyes social profiles
Digital presenceTreehouse Eyes financial estimates
Financial estimateRevenue estimate
Valuation estimate
Treehouse Eyes leadership team
Management profileNumber of profiles
Profiles3 records
Treehouse Eyes funding detail
Funding detailFunding overview
Funding rounds2 records
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Treehouse Eyes M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Treehouse Eyes
What does Treehouse Eyes do?
Treehouse Eyes provides pediatric myopia management services for children with nearsightedness, offering FDA-approved soft contact lenses (MiSight 1-day), custom overnight orthokeratology lenses (KIDS Lenses), prescription atropine eye drops, and Stellest myopia control glasses. Treatment is delivered through a network of partner optometric practices supported by the proprietary Treehouse Vision System clinical protocol and AI-assisted treatment planning.
Is Treehouse Eyes a public or private company?
Treehouse Eyes is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Treehouse Eyes founded?
Treehouse Eyes was founded in 2016. It employs 11 to 50 people.
Where is Treehouse Eyes based?
Treehouse Eyes is headquartered in Boulder, United States, in the North America region.
How does Treehouse Eyes make money?
Two revenue lines are on record. Partner Practice Subscriptions are the primary driver. The others are myopia Treatment Services.
Who are Treehouse Eyes's main competitors?
Broad incumbents on record are CooperVision (MiSight), EssilorLuxottica (Stellest), Pearle Vision and LensCrafters. Direct peers are Brien Holden Vision Institute and Ortho-K Networks (orthokeratology practices). Emerging players are MyopiaCare (by Vision Source) and Pediatric Eye Center (MyKidsEyes). Others are Atropine 0.01% Compounding Pharmacies (e.g., ImprimisRx) and Vision Council of America (myopia education initiatives).
Does Treehouse Eyes have an API?
No public API is recorded for Treehouse Eyes.
What industry is Treehouse Eyes in?
Treehouse Eyes's product category is Pediatric Myopia Management. Its primary akta.pro industry code is HLAKAKAK, Contact Lens Specialty & Myopia Control, with a secondary code of HLAKAKAB, Optometry Clinics (Primary Eye Care). Its NAICS code is 62132 and its SIC code is 3851.